Pfizer victory in Vyndaqel copay lawsuit could kneecap the government's only control on prices, lawyer warns

After coughing up nearly $24 million in a federal settlement over donations to patient charities, Pfizer went on the offensive last summer and took the U.S.' anti-kickback policies to task. Late last month, the drug giant got its day in court.